▲ Peaking
Health
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
The National Institutes of Health launches a major public-private partnership focused on developing cancer vaccines.
Cancer Vaccines
11 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
Cancer Vaccines Are the N.I.H’s Next ‘Big Bet’
Cancer vaccines emerge as a major focus for the N.I.H. amid growing clinical developments.
◼ Archived
Health
Divergent trial results on cancer vaccines have the field grappling with hard questions
The oncology community is facing critical questions as divergent trial results emerge regarding the efficacy and scale of cancer vaccines.
◼ Archived
Health
Exclusive | She was ready to die. Now she’s in remission
New developments in personalized mRNA cancer vaccines show promise for melanoma and breast cancer, though hurdles in public perception remain.
◼ Archived
Business
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036)
Recent coverage examines the growing cancer vaccines market alongside Phase 3 mRNA vaccine results and personalised medicine strategies.
◼ Archived
Health
A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 holds ✗
Personalized mRNA cancer vaccines offer new hope. We explain
Personalized mRNA cancer vaccines are gaining momentum following Phase III success in melanoma and expanded global clinical trials.
◼ Archived
Business
🔮 fades ✓
It now seems possible to vaccinate against cancer
Advancements in mRNA technology are driving the development of cancer vaccines, specifically targeting melanoma and expanding medical breakthroughs.
◼ Archived
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 holds
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.